DGAP-News: MeVis Medical Solutions AG: MeVis' leap in sales and profits in the third quarter
(firmenpresse) - DGAP-News: MeVis Medical Solutions AG / Key word(s): Quarter
Results/Interim Report
MeVis Medical Solutions AG: MeVis' leap in sales and profits in the
third quarter
11.11.2013 / 07:30
---------------------------------------------------------------------
Accumulated revenues exceed previous year by 9 % because of a very strong
third quarter
- After the first nine month consolidated sales increased by 9 % year on
year to EUR 11.1 million
- Maintenance business contributes 42 % to the revenues (prev. year: 44
%)
- Earnings before interest and taxes (EBIT) again significantly increased
by EUR 1.2 million to EUR 3.2 million (prev. year: EUR 2.0 million)
- Consolidated net profit also increased considerably to EUR 2.9 million
(prev. year: EUR 0.5 million)
- Liquidity raised to EUR 11.7 million (December 31, 2012: EUR 8.7
million)
- In 2014, however, planned increase of resources due to increased
customer requirements on existing products
Bremen, November 11, 2013 - Today, MeVis Medical Solutions AG [ISIN:
DE000A0LBFE4], a leading software provider for the medical imaging market,
announced its results for the first three quarters of 2013.
Sales in the third quarter of 2013 came to EUR 4,210 k, up a considerable
30 % on the third quarter of 2012 (prev. year. EUR 3,235 k). Sales in the
first nine months of 2013 totaled EUR 11,072 k, which is an increase of 9 %
year on year (prev. year: EUR 10,113 k). Maintenance and service revenues
rose once again by 3 % to EUR 4,615 k (prev. year: EUR 4,499 k) and account
for 42 % of total sales (prev. year: 44 %). License sales even increased by
10 % to EUR 5,773 k (prev. year: EUR 5,257 k). Higher grants for
development costs and maintenance have also contributed to sales in 2013.
Sales in the Digital Mammography segment increased considerably by 11 % to
EUR 8,516 k (prev. year: EUR 7,694 k). Sales in the Other Diagnostics
segment also increased, by 6 % to EUR 2,556 k (prev. year: EUR 2,419 k).
Capitalized development expenses were almost halved in the first nine
months of 2013, falling by 44 % year on year to EUR 1,075 k (prev. year:
EUR 1,908 k).
Operating costs in the third quarter of 2013 were up slightly on the
prior-year quarter; however, operating costs in the first nine months of
2013 are still down significantly year on year. Personnel expenses amounted
to EUR 1,963 k, up 7 % on the prior-year quarter. For the first three
quarters, this corresponds to a total drop of 7 %. Other operating expenses
amounted to EUR 485 k in the third quarter, which corresponds to an
increase of 11 % on the prior-year quarter. However, for the first three
quarters of 2013, this also represents a drop of 12 %.
Depreciation and amortization came to EUR 1,596 k (down 32 % year on year),
resulting in EBIT (earnings before interest and taxes) of EUR 3,162 k (up a
significant 62 % on the prior-year figure of EUR 1,951 k) and an EBIT
margin of 29 % (prev. year: 19 %).
With a financial result of EUR -107 k and very low income tax expenses, the
first nine months of 2013 closed on a very positive note, with consolidated
net profit of EUR 2,949 k (prev. year: EUR 472 k). This resulted in
earnings per share of EUR 1.71 (prev. year: EUR 0.27).
Cash and cash equivalents also increased in the third quarter of 2013 and
amounted to EUR 11,714 k as of September 30, 2013 (compared to EUR 8,665k
as of December 31, 2012).
'Based on the performance so far, on November 4th, we once again raised our
forecast for 2013. We currently anticipate that sales for fiscal year 2013
will be higher than the level in fiscal year 2012. In addition, we expect
consolidated earnings before interest and taxes (EBIT) well above the
prior-year figure and a positive cash flow from operating activities.' said
Dr. Robert Hannemann, CFO of MeVis Medical Solutions AG.
'Following the completion of the consolidation measures, we continue to
focus heavily on the development and implementation of measures designed to
generate future sales growth, where we can already see the first project
successes.' added Marcus Kirchhoff, CEO of MeVis Medical Solutions AG. 'We
will, at the end of this year, launch first services, such as the MeVis
Online Academy and MeVis Online CAD as part of our business with
internet-based services. Furthermore, due to increased customer
requirements for existing products we will, for the first time again,
increase our resources in the coming quarters.'
The financial reports of the company can be downloaded here:
http://www.mevis.de/ir_finanzberichte.html
End of Corporate News
---------------------------------------------------------------------
11.11.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: ir(at)mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
238928 11.11.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.11.2013 - 07:30 Uhr
Sprache: Deutsch
News-ID 314734
Anzahl Zeichen: 9791
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 272 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: MeVis Medical Solutions AG: MeVis' leap in sales and profits in the third quarter"
steht unter der journalistisch-redaktionellen Verantwortung von
MeVis Medical Solutions AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
